13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001232621
申报总市值
US$22.0亿
US$22.0亿
154 檔
13.9%
Q3 2024 季度申报显示，Tang Capital Management LLC 披露的美股组合总市值为 US$22.0亿，涵盖 154 个不同之权益投资仓位。
在 Q3 2024，Tang Capital Management LLC 操作展现出积极扩展与加仓意向。本季共新建仓 35 个新仓位，并对 43 个既有持股进行加仓（合计增持 78 档），相较减仓与清仓仓位显著占优。
在资产配置集中度方面，Tang Capital Management LLC 的前 5 大核心持股（包含 EOLS, TARS, AUPH 等）合计占整体申报市值的 13.9%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | EOLS | Evolus Inc | 股票-其他 | 5.61% | -0.10% | EXIT | |
| 2 | TARS | Tarsus Pharmaceuticals Inc | 股票-其他 | 5.30% | +0.25% | — | |
| 3 | AUPH | Aurinia Pharmaceuticals Inc | 股票-其他 | 3.79% | +0.85% | +160.10% | |
| 4 | VRDN | Viridian Therapeutics Inc | 股票-其他 | 3.65% | -0.28% | +61.02% | |
| 5 | MIRM | Mirum Pharmaceuticals Inc | 股票-其他 | 3.59% | +0.77% | — | |
| 6 | 4XC1 | Kalvista Pharmaceuticals Inc | 股票-其他 | 3.57% | -4.68% | EXIT | |
| 7 | ANAB | Anaptysbio Inc | 股票-其他 | 3.18% | +0.33% | — | |
| 8 | IMCR | Immunocore Holdings Plc-adr | 股票-其他 | 2.46% | -0.24% | +172.58% | |
| 9 | PCVX | Vaxcyte Inc | 股票-其他 | 2.45% | — | — | |
| 10 | BNTX | Biontech Se-adr | 股票-其他 | 2.29% | -0.13% | — | |
| 11 | ANIP | Ani Pharmaceuticals Inc | 股票-其他 | 1.92% | -0.10% | — | |
| 12 | PTCT | Ptc Therapeutics Inc | 股票-医疗保健 | 1.86% | +0.37% | — | |
| 13 | RLAY | Relay Therapeutics Inc | 股票-其他 | 1.80% | — | — | |
| 14 | 2662247D | Iteos Therapeutics Inc | 股票-其他 | 1.76% | — | — | |
| 15 | APLT | Applied Therapeutics Inc | 股票-其他 | 1.66% | — | +17.17% | |
| 16 | ACAD | Acadia Pharmaceuticals Inc | 股票-医疗保健 | 1.65% | — | — | |
| 17 | ITCIEUR | Intra-cellular Therapies Inc | 股票-其他 | 1.57% | — | — | |
| 18 | DVAX | Dynavax Technologies CORP | 股票-其他 | 1.51% | — | -24.00% | |
| 19 | LKFT | Lakefront Biotherapeutic-adr | 股票-其他 | 1.44% | -0.61% | +1158.79% | |
| 20 | GSK | Gsk Plc-spon Adr | 股票-医疗保健 | 1.31% | — | +12.50% | |
| 21 | LENZ | Lenz Therapeutics Inc | 股票-其他 | 1.30% | -0.09% | +2.58% | |
| 22 | NVDA | Nvidia CORP | 股票-科技 | 1.28% | — | +28.44% | |
| 23 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 1.23% | — | — | |
| 24 | ALT | Altimmune Inc | 股票-其他 | 1.21% | -0.01% | — | |
| 25 | ✓ | Avadel Pharmaceuticals PLC ADR | 股票-其他 | 1.15% | — | — | |
| 26 | KNSA | Kiniksa Pharmaceuticals International, plc | 股票-其他 | 1.12% | +1.03% | +0.53% | |
| 27 | JAZZ | Jazz Pharmaceuticals plc | 股票-医疗保健 | 1.11% | — | — | |
| 28 | AVIR | Atea Pharmaceuticals Inc | 股票-其他 | 1.10% | -0.30% | +2.91% | |
| 29 | CGEM | Cullinan Therapeutics Inc | 股票-其他 | 1.10% | — | — | |
| 30 | META | Meta Platforms Inc-class A | 股票-通信服务 | 1.06% | — | +126.88% | |
| 31 | RCKT | Rocket Pharmaceuticals Inc | 股票-其他 | 0.99% | — | — | |
| 32 | ZYME | Zymeworks Inc | 股票-其他 | 0.99% | — | — | |
| 33 | REPL | Replimune Group Inc | 股票-其他 | 0.94% | — | +48.99% | |
| 34 | RVNCEUR | Revance Therapeutics Inc | 股票-其他 | 0.93% | — | +525.00% | |
| 35 | CRGX | Cargo Therapeutics Inc | 股票-其他 | 0.92% | — | +22.36% | |
| 36 | TDOC | Teladoc Health Inc | 股票-医疗保健 | 0.92% | — | +40.00% | |
| 37 | NVAX | Novavax Inc | 股票-医疗保健 | 0.90% | — | — | |
| 38 | CRSP | CRISPR Therapeutics AG | 股票-医疗保健 | 0.89% | — | -15.80% | |
| 39 | CRBP | Corbus Pharmaceuticals Holdi | 股票-其他 | 0.88% | — | — | |
| 40 | TORCEUR | Adicet Bio Inc | 股票-其他 | 0.85% | — | — | |
| 41 | AZNN | Astrazeneca Plc-spons Adr | 股票-其他 | 0.83% | — | — | |
| 42 | HRMY | Harmony Biosciences Holdings | 股票-其他 | 0.80% | — | — | |
| 43 | VNDA | Vanda Pharmaceuticals Inc | 股票-其他 | 0.79% | — | +9.29% | |
| 44 | IMNM | Immunome Inc | 股票-其他 | 0.75% | — | — | |
| 45 | CTMX | Cytomx Therapeutics Inc | 股票-其他 | 0.66% | — | +0.25% | |
| 46 | NUVB | Nuvation Bio Inc | 股票-其他 | 0.64% | +0.16% | +3.95% | |
| 47 | ELAN | Elanco Animal Health Inc | 股票-医疗保健 | 0.63% | — | — | |
| 48 | ✓ | Hillevax Inc | 股票-其他 | 0.62% | — | — | |
| 49 | OTLK | Outlook Therapeutics Inc | 股票-其他 | 0.59% | — | -3.70% | |
| 50 | ONC | Beone Medicines Ltd-adr | 股票-其他 | 0.59% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | BNTX | Biontech Se-adr | +2.3% | NEW | 新建仓 |
| 2 | AUPH | Aurinia Pharmaceuticals Inc | +2.2% | +160.10% | 加仓 |
| 3 | VRDN | Viridian Therapeutics Inc | +1.8% | +61.02% | 加仓 |
| 4 | RLAY | Relay Therapeutics Inc | +1.8% | NEW | 新建仓 |
| 5 | 2662247D | Iteos Therapeutics Inc | +1.8% | NEW | 新建仓 |
| 6 | LKFT | Lakefront Biotherapeutic-adr | +1.3% | +1158.79% | 加仓 |
| 7 | NBIX | Neurocrine Biosciences Inc | +1.2% | NEW | 新建仓 |
| 8 | IMCR | Immunocore Holdings Plc-adr | +1.1% | +172.58% | 加仓 |
| 9 | NVAX | Novavax Inc | +0.9% | NEW | 新建仓 |
| 10 | CRBP | Corbus Pharmaceuticals Holdi | +0.9% | NEW | 新建仓 |
| 11 | RVNCEUR | Revance Therapeutics Inc | +0.8% | +525.00% | 加仓 |
| 12 | ELAN | Elanco Animal Health Inc | +0.6% | NEW | 新建仓 |
| 13 | ✓ | Hillevax Inc | +0.6% | NEW | 新建仓 |
| 14 | APLT | Applied Therapeutics Inc | +0.6% | +17.17% | 加仓 |
| 15 | ALXO | Alx Oncology Holdings Inc | +0.6% | NEW | 新建仓 |
| 16 | BLCO | Bausch + Lomb CORP | +0.5% | NEW | 新建仓 |
| 17 | META | Meta Platforms Inc-class A | +0.5% | +126.88% | 加仓 |
| 18 | 260 | Centessa Pharmaceuticals-adr | +0.5% | NEW | 新建仓 |
| 19 | ✓ | +0.4% | NEW | 新建仓 | |
| 20 | NUVL | Nuvalent Inc-a | +0.4% | NEW | 新建仓 |
| 21 | ALMS | Alumis Inc | +0.3% | NEW | 新建仓 |
| 22 | ABCL | Abcellera Biologics Inc | +0.3% | +398.16% | 加仓 |
| 23 | SNY | Sanofi-adr | +0.3% | NEW | 新建仓 |
| 24 | EOLS | Evolus Inc | +0.3% | — | 不变 |
| 25 | HELP | Cybin Inc | +0.3% | NEW | 新建仓 |
| 26 | CMPX | Compass Therapeutics Inc | +0.2% | NEW | 新建仓 |
| 27 | REPL | Replimune Group Inc | +0.2% | +48.99% | 加仓 |
| 28 | ✓ | +0.2% | NEW | 新建仓 | |
| 29 | CCCC | C4 Therapeutics Inc | +0.2% | +250.00% | 加仓 |
| 30 | TYRA | Tyra Biosciences Inc | +0.2% | +255.26% | 加仓 |
| 31 | SWTXUSD | Springworks Therapeutics Inc | +0.2% | NEW | 新建仓 |
| 32 | TBPH | Theravance Biopharma, Inc. | +0.2% | NEW | 新建仓 |
| 33 | PCVX | Vaxcyte Inc | +0.1% | — | 不变 |
| 34 | LQDA | Liquidia CORP | +0.1% | +128.57% | 加仓 |
| 35 | PCRX | Pacira Biosciences Inc | +0.1% | NEW | 新建仓 |
| 36 | DSGN | Design Therapeutics Inc | +0.1% | — | 不变 |
| 37 | PYPL | Paypal Holdings Inc | +0.1% | NEW | 新建仓 |
| 38 | NKE | Nike Inc -cl B | +0.1% | NEW | 新建仓 |
| 39 | UNH | Unitedhealth Group Inc | +0.1% | NEW | 新建仓 |
| 40 | JNJ | Johnson & Johnson | +0.1% | NEW | 新建仓 |
| 41 | LAB | Standard Biotools Inc | +0.1% | NEW | 新建仓 |
| 42 | ONC | Beone Medicines Ltd-adr | +0.1% | — | 不变 |
| 43 | PFE | Pfizer Inc | +0.1% | NEW | 新建仓 |
| 44 | HD | Home Depot Inc | +0.1% | +246.69% | 加仓 |
| 45 | VZ | Verizon Communications Inc | +0.1% | +284.34% | 加仓 |
| 46 | ZYME | Zymeworks Inc | 0% | — | 不变 |
| 47 | TECX | Tectonic Therapeutic Inc | 0% | — | 不变 |
| 48 | WMT | Walmart Inc | 0% | +185.31% | 加仓 |
| 49 | BRK-B | Berkshire Hathaway Inc-cl B | 0% | +192.41% | 加仓 |
| 50 | KO | Coca-cola Co/the | 0% | +247.46% | 加仓 |
根据 SEC 官方 Form 13F 申报备案，Tang Capital Management LLC 在 Q3 2024 季度的美股持仓总市值约为 US$22.0亿，共申报了 154 个公开持股仓位。
在 Q3 2024 季度，Tang Capital Management LLC 按市值排列的前三大核心持股分别为：EOLS (5.6%)、TARS (5.3%)、AUPH (3.8%)。其中最大持股仓位 EOLS 占据整体投资组合约 5.6% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
BNTX
市值: US$3206.8万
本季最大获利了结 / 清仓标的
LLY
前期市值: US$2444.5万
在 Q3 2024 季度中，Tang Capital Management LLC 共进行了 101 项持仓异动，包含新建仓 35 个仓位、加仓 43 个仓位、减仓 14 个仓位以及清仓 9 个仓位。 其中最大新建仓标的为 BNTX。 本季清仓仓位包含 LLY。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。